BARD - Investor Relations - Financial Information

Financial Information > Press Releases

Print this page

<< Back

Court Rules in Favor of Bard in Class Action Lawsuit

MURRAY HILL, N.J.--(BUSINESS WIRE)--Sep. 29, 2009-- C. R. Bard, Inc. (NYSE: BCR) today announced that the U.S. District Court, Eastern District of Missouri, has granted Bard's summary judgment motion and dismissed with prejudice all counts in the previously-disclosed class action lawsuit entitled St. Francis Medical Center, et al. v. C. R. Bard, Inc., et al. (Civil Action No. 1:07-cv-00031, United States District Court, Eastern District of Missouri, Southeastern Division). St. Francis may appeal the court's decision to the Eighth Circuit Court of Appeals.

C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

Source: C. R. Bard, Inc.

C. R. Bard, Inc.
Investor Relations:
Eric J. Shick, 908-277-8413
Vice President, Investor Relations
or
Media Relations:
Scott T. Lowry, 908-277-8365
Vice President and Treasurer

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding C.R. Bard, Inc.'s business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year.